79932 Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 

2. CKD–NEW–12: Increase the 

proportion of people with chronic 

kidney disease and severe albuminuria 

who receive glucose-lowering 

medications based on the most recent 

guidelines. Data source: National Health 

and Nutrition Examination Survey 

(NHANES). 

3. ECBP–NEW–02: Increase the 

proportion of medical schools that 

include environmental health content in 

a required learning experience. Data 

source: American Association of 

Colleges of Osteopathic Medicine 

(AACOM) and Association of American 

Medical Colleges (AAMC) (2022 Annual 

Osteopathic Medical School 

Questionnaire and Liaison Committee 

on Medical Education (LCME); Annual 

Medical School Questionnaire Part II). 

4. ECBP–NEW–03: Increase the 

proportion of undergraduate nursing 

and graduate nurse practitioner training 

programs that include environmental 

health content in a required learning 

experience. Data source: American 

Association of Colleges of Nursing 

(AACN) and National Organization of 

Nurse Practitioner Faculties (NONPF) 

(2022 American Association of Colleges 

of Nursing Healthy People 2030 

Curriculum Survey; 2022 National 

Organization of Nurse Practitioner 

Faculties Healthy People 2030 

Curriculum Survey). 

5. ECBP–NEW–04: Increase the 

proportion of physician assistant (PA) 

training programs that include 

environmental health content in a 

required learning experience. Data 

source: Physician Assistant Education 

Association (PAEA) (2022 Physician 

Assistant Education Association 

Healthy People 2030 Survey). 

6. ECBP–NEW–05: Increase the 

proportion of colleges and schools of 

pharmacy with Doctor of Pharmacy 

(PharmD) degree programs that include 

environmental health content in a 

required learning experience. Data 

source: American Association of 

Colleges of Pharmacy (AACP) (2022 

American Association of Colleges and 

Pharmacy Healthy People 2030 Survey). 

7. ECBP–NEW–06: Increase the 

proportion of colleges and schools of 

dentistry with Doctor of Dental Surgery 

(DDS) and/or Doctor of Dental Medicine 

(DMD) degree programs that include 

environmental health content in a 

required learning experience. Data 

source: American Dental Education 

Association (ADEA) (2022 ADEA 

Healthy People 2030 Survey). 

8. EH–NEW–12: Reduce deaths related 

to heat. This objective is currently a 

development objective, EH–D02. Data 

source: National Vital Statistics 

System—Mortality. 

9. HOSCD–NEW–13: Increase the 

proportion of adults with 

communication disorders of voice, 

swallowing, speech, or language who 

have seen a health care specialist for 

evaluation or treatment in the past 12 

months. Data source: National Health 

Interview Survey (NHIS), CDC/NCHS. 

10. IID–NEW–18: Increase the 

proportion of pregnant women who 

receive 1 dose of the tetanus-diphtheriaacellular pertussis (Tdap) vaccine 

during pregnancy. Data source: National 

Health Interview Survey (NHIS), CDC/ 

NCHS. 

11. IID–NEW–19: Increase the 

proportion of adults who receive the 

recommended age-appropriate vaccine. 

Data source: National Health Interview 

Survey (NHIS), CDC/NCHS. 

12. MICH–NEW–21: Reduce the rate of 

hypertension in pregnancy (preexisting 

and pregnancy-associated hypertension) 

among delivery hospitalizations. Data 

source: Healthcare Cost and Utilization 

Project—National (Nationwide) 

Inpatient Sample (HCUP–NIS), Agency 

for Healthcare Research and Quality 

(AHRQ). 

The public also is invited to provide 

comment on the current Healthy People 

2030 objectives and propose additional 

core, developmental, or research 

objectives for consideration that address 

critical public health issues. Proposed 

new objectives must meet all the 

objective selection criteria (see below). 

The public is also invited to propose 

new topics to be considered for 

inclusion in Healthy People 2030. 

Objective Selection Criteria 

Core Objectives 

Core objectives must meet the 

following five criteria to be included in 

Healthy People 2030. Core objectives 

should (1) have a reliable, nationally 

representative data source with baseline 

data no older than 2015; (2) have at least 

two additional data points beyond the 

baseline during the decade; (3) be of 

national importance; (4) have effective, 

evidence-based interventions available 

to achieve the objective; and (5) have 

data to help address disparities and 

achieve health equity. 

Developmental Objectives 

Developmental objectives will have 

the following characteristics: (1) 

represent high priority issues; (2) do not 

have reliable baseline data yet; and (3) 

have evidence-based interventions 

available. 

Research Objectives 

Research objectives will have the 

following characteristics: (1) represent 

key opportunities to make progress in 

areas with limited prior research, a high 

health or economic burden, or 

significant disparities between 

population groups; (2) may or may not 

have reliable baseline data; and (3) do 

not have evidence-based interventions 

available. 

Written comments and evidencebased information should be submitted 

by email to HP2030Comment@hhs.gov 

by 11:59 p.m. ET on October 31, 2024. 

Comments received in response to this 

notice will be reviewed and considered 

by the Healthy People topic area 

workgroups, Federal Interagency 

Workgroup on Healthy People 2030, and 

other federal subject matter experts. 

Paul Reed, 

Deputy Assistant Secretary for Health, Office 

of Disease Prevention and Health Promotion. 

[FR Doc. 2024–22519 Filed 9–30–24; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Small Research Grants (R03) 

for New Investigators and Secondary Data 

Analysis PARs Review. 

Date: November 6–7, 2024. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Thomas John O’Farrell, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, National Institute of Dental and 

Craniofacial Research, 31 Center Drive, 

Bethesda, M.D. 20892, (301) 584–4859, email: 

tom.ofarrell@nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 79933 

Emphasis Panel; Assessment of Climate at 

Institutions (ACt) Award (RC2—Clinical Trial 

Not Allowed). 

Date: November 8, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Christopher Campbell, 

Ph.D., M.D., Scientific Review Officer, 

Scientific Review Branch, Division of 

Extramural Activities, National Institute of 

Dental and Craniofacial Research, 31 Center 

Drive, Bethesda, M.D. 20892, (301) 827–4603, 

email: christopher.campbell@nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Prospective Observational 

or Biomarker Validation Study Cooperative 

Agreement. 

Date: November 12, 2024. 

Time: 3:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Christopher Campbell, 

Ph.D., M.D., Scientific Review Officer, 

Scientific Review Branch, Division of 

Extramural Activities, National Institute of 

Dental and Craniofacial Research, 31 Center 

Drive, Bethesda, MD 20892, (301) 827–4603, 

email: christopher.campbell@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: September 26, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22529 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Literature Selection 

Technical Review Committee, October 

24–25, 2024, 8:30 a.m. to 5 p.m., which 

was published in the Federal Register 

on July 23, 2024, 89 FR 59744. 

This meeting will be amended to 

change the meeting time from 8:30 a.m. 

to 5 p.m. to 10 a.m. to 4 p.m. for both 

days. An open session is added from 

10–10:30 a.m. on October 25, 2024. 

The open session of the meeting will 

be virtual. Any interested person may 

file written comments with the 

committee by forwarding the statement 

to the Contact Person listed on this 

notice no later than 7 days prior to the 

meeting. The statement should include 

the name, address, telephone number 

and, when applicable, the business or 

professional affiliation of the interested 

person. Individuals who need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify Dianne 

Babski, Associate Director, Division of 

Library Operations, National Library of 

Medicine at babskid@mail.nih.gov. The 

open session will be videocast and can 

be accessed from the NIH Videocast 

website at https://videocast.nih.gov/. 

Dated: September 25, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22436 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Heart, Lung, 

and Blood Advisory Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

access from the NIH Videocasting and 

Podcase website http://videocast.

nih.gov/ or https://www.nhlbi.nih.gov/ 

about/advisory-and-peer-reviewcommittees/advisory-council. 

Name of Committee: National Heart, Lung, 

and Blood Advisory Council. 

Date: October 29, 2024. 

Open: 8:00 a.m. to 9:00 a.m., 3:00 p.m. to 

5:00 p.m. 

Agenda: To discuss program policies and 

issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892. 

Meeting Format: In Person. 

Virtual Access: The meeting will be 

videocast and can be accessed from the NIH 

Videocast. http://videocast.nih.gov/or https:// 

www.nhlbi.nih.gov/about/advisory-and-peerreview-committees/advisory-council. Please 

note, the link to the videocast meeting will 

be posted within a week of the meeting date. 

Contact Person: Charisee Lamar, Ph.D., 

M.P.H., Director, Division of Extramural 

Research Activities, National Heart, Lung, 

and Blood Institute, National Institutes of 

Health, 6705 Rockledge Drive, Room 206–Q, 

Bethesda, MD 20892–7924, (301) 827–5517, 

Email: lamarc@mail.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on the notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nhlbi.nih.gov/about/advisory-and-peerreview-committees/advisory-council where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 26, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22523 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 


khammond on DSKJM1Z7X2PROD with NOTICES